{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:00:01Z","timestamp":1794024001021,"version":"4.8.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,1,21]]},"DOI":"10.7759\/cureus.21473","type":"journal-article","created":{"date-parts":[[2022,1,21]],"date-time":"2022-01-21T13:41:15Z","timestamp":1642772475000},"source":"Crossref","is-referenced-by-count":8,"title":["Opioid Use in Patients With Sickle Cell Disease During a Vaso-Occlusive Crisis: A Systematic Review"],"prefix":"10.7759","author":[{"given":"Hadia","family":"Arzoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirra","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isra","family":"Sahib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Fondeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth","family":"Escudero Mendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raneem K","family":"Hamouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubna","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24948","article-title":"A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD)","volume":"93","author":"Tanabe P","year":"2018","unstructured":"Tanabe P, Silva S, Bosworth HB, et al.. A randomized controlled trial comparing two vaso-occlusive episode (VOE) protocols in sickle cell disease (SCD). Am J Hematol. 2018, 93:159-68. 10.1002\/ajh.24948","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21807","article-title":"The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database","volume":"85","author":"Lanzkron S","year":"2010","unstructured":"Lanzkron S, Carroll CP, Haywood C Jr. The burden of emergency department use for sickle-cell disease: an analysis of the national emergency department sample database. Am J Hematol. 2010, 85:797-9. 10.1002\/ajh.21807","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-04-383430","article-title":"Sickle cell pain: a critical reappraisal","volume":"120","author":"Ballas SK","year":"2012","unstructured":"Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood. 2012, 120:3647-56. 10.1182\/blood-2012-04-383430","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.36469\/jheor.2020.13348","article-title":"Association between vaso-occlusive crises and opioid prescriptions among patients with sickle cell disease: a retrospective claims-based study","volume":"7","author":"Kang HA","year":"2020","unstructured":"Kang HA, Barner JC, Richards KM, Bhor M, Paulose J, Kutlar A. Association between vaso-occlusive crises and opioid prescriptions among patients with sickle cell disease: a retrospective claims-based study. J Health Econ Outcomes Res. 2020, 7:94-101. 10.36469\/jheor.2020.13348","journal-title":"J Health Econ Outcomes Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2017.1.525","article-title":"Optimizing the care model for an uncomplicated acute pain episode in sickle cell disease","volume":"2017","author":"Telfer P","year":"2017","unstructured":"Telfer P, Kaya B. Optimizing the care model for an uncomplicated acute pain episode in sickle cell disease. Hematol Am Soc Hematol Educ Program. 2017, 2017:525-33. 10.1182\/asheducation-2017.1.525","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-06713-1_12","article-title":"Clinical manifestations and treatment of adult sickle cell disease","author":"Costa FF","year":"2016","unstructured":"Costa FF, Fertrin KY. Clinical manifestations and treatment of adult sickle cell disease. Sickle Cell Anemia. Costa FF, Conran N (ed): Springer, Cham, Switzerland; 2016. 1:285-318. 10.1007\/978-3-319-06713-1_12"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24534","article-title":"Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease","volume":"91","author":"Brandow AM","year":"2016","unstructured":"Brandow AM, Nimmer M, Simmons T, et al.. Impact of emergency department care on outcomes of acute pain events in children with sickle cell disease. Am J Hematol. 2016, 91:1175-80. 10.1002\/ajh.24534","journal-title":"Am J Hematol"},{"key":"ref8","article-title":"Approach to the vaso-occlusive crisis in adults with sickle cell disease","volume":"61","author":"Yale SH","year":"2000","unstructured":"Yale SH, Nagib N, Guthrie T. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Am Fam Physician. 2000, 61:1349-64.","journal-title":"Am Fam Physician"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4291","article-title":"Characterization of opioid use in sickle cell disease","volume":"27","author":"Han J","year":"2018","unstructured":"Han J, Zhou J, Saraf SL, Gordeuk VR, Calip GS. Characterization of opioid use in sickle cell disease. Pharmacoepidemiol Drug Saf. 2018, 27:479-86. 10.1002\/pds.4291","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-13-74","article-title":"Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial","volume":"13","author":"Barrett MJ","year":"2012","unstructured":"Barrett MJ, Cronin J, Murphy A, et al.. Intranasal fentanyl versus intravenous morphine in the emergency department treatment of severe painful sickle cell crises in children: study protocol for a randomised controlled trial. Trials. 2012, 13:74. 10.1186\/1745-6215-13-74","journal-title":"Trials"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14740\/jh828","article-title":"Opioid use in adults with sickle cell disease hospitalized during vaso-occlusive crisis: a systematic review","volume":"10","author":"Osborne JC","year":"2021","unstructured":"Osborne JC, Osakwe Z, Odlum M. Opioid use in adults with sickle cell disease hospitalized during vaso-occlusive crisis: a systematic review. J Hematol. 2021, 10:46-52. 10.14740\/jh828","journal-title":"J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S185582","article-title":"Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management","volume":"11","author":"Uwaezuoke SN","year":"2018","unstructured":"Uwaezuoke SN, Ayuk AC, Ndu IK, Eneh CI, Mbanefo NR, Ezenwosu OU. Vaso-occlusive crisis in sickle cell disease: current paradigm on pain management. J Pain Res. 2018, 11:3141-50. 10.2147\/JPR.S185582","journal-title":"J Pain Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/jpepsy\/jsu072","article-title":"Opioid misuse behaviors in adolescents and young adults in a hematology\/oncology setting","volume":"39","author":"Ehrentraut JH","year":"2014","unstructured":"Ehrentraut JH, Kern KD, Long SA, An AQ, Faughnan LG, Anghelescu DL. Opioid misuse behaviors in adolescents and young adults in a hematology\/oncology setting. J Pediatr Psychol. 2014, 39:1149-60. 10.1093\/jpepsy\/jsu072","journal-title":"J Pediatr Psychol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003583","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"18","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021, 18:e1003583. 10.1371\/journal.pmed.1003583","journal-title":"PLoS Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003350.pub3","article-title":"Withdrawn: pain management for sickle cell disease in children and adults","volume":"2014","author":"Dunlop R","year":"2014","unstructured":"Dunlop R, Bennett KC. Withdrawn: pain management for sickle cell disease in children and adults. Cochrane Database Syst Rev. 2014, 2014:CD003350. 10.1002\/14651858.CD003350.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12879","article-title":"Management of the acute painful crisis in sickle cell disease-a re-evaluation of the use of opioids in adult patients","volume":"166","author":"Telfer P","year":"2014","unstructured":"Telfer P, Bahal N, Lo A, Challands J. Management of the acute painful crisis in sickle cell disease-a re-evaluation of the use of opioids in adult patients. Br J Haematol. 2014, 166:157-64. 10.1111\/bjh.12879","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/540154","article-title":"Morphine for the treatment of pain in sickle cell disease","volume":"2015","author":"Gupta M","year":"2015","unstructured":"Gupta M, Msambichaka L, Ballas SK, Gupta K. Morphine for the treatment of pain in sickle cell disease. Sci World J. 2015, 2015:540154. 10.1155\/2015\/540154","journal-title":"Sci World J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0216414","article-title":"Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: the emergency department providers' perspective","volume":"14","author":"Masese RV","year":"2019","unstructured":"Masese RV, Bulgin D, Douglas C, Shah N, Tanabe P. Barriers and facilitators to care for individuals with sickle cell disease in central North Carolina: the emergency department providers' perspective. PLoS One. 2019, 14:e0216414. 10.1371\/journal.pone.0216414","journal-title":"PLoS One"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.07.037","article-title":"Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit","volume":"36","author":"Molokie RE","year":"2018","unstructured":"Molokie RE, Montminy C, Dionisio C, et al.. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit. Am J Emerg Med. 2018, 36:88-92. 10.1016\/j.ajem.2017.07.037","journal-title":"Am J Emerg Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13430","article-title":"The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management","volume":"105","author":"Darbari DS","year":"2020","unstructured":"Darbari DS, Sheehan VA, Ballas SK. The vaso-occlusive pain crisis in sickle cell disease: definition, pathophysiology, and management. Eur J Haematol. 2020, 105:237-46. 10.1111\/ejh.13430","journal-title":"Eur J Haematol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2018.01.014","article-title":"Key components of pain management for children and adults with sickle cell disease","volume":"32","author":"Brandow AM","year":"2018","unstructured":"Brandow AM, DeBaun MR. Key components of pain management for children and adults with sickle cell disease. Hematol Oncol Clin North Am. 2018, 32:535-50. 10.1016\/j.hoc.2018.01.014","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.4103\/sja.SJA_228_17","article-title":"Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patients","volume":"11","author":"Al-Anazi A","year":"2017","unstructured":"Al-Anazi A, Al-Swaidan L, Al-Ammari M, et al.. Assessment of patient-controlled analgesia versus intermittent opioid therapy to manage sickle-cell disease vaso-occlusive crisis in adult patients. Saudi J Anaesth. 2017, 11:437-41. 10.4103\/sja.SJA_228_17","journal-title":"Saudi J Anaesth"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2007.06.040","article-title":"Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment","volume":"152","author":"Frei-Jones MJ","year":"2008","unstructured":"Frei-Jones MJ, Baxter AL, Rogers ZR, Buchanan GR. Vaso-occlusive episodes in older children with sickle cell disease: emergency department management and pain assessment. J Pediatr. 2008, 152:281-5. 10.1016\/j.jpeds.2007.06.040","journal-title":"J Pediatr"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27420","article-title":"Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis","volume":"65","author":"Payne J","year":"2018","unstructured":"Payne J, Aban I, Hilliard LM, et al.. Impact of early analgesia on hospitalization outcomes for sickle cell pain crisis. Pediatr Blood Cancer. 2018, 65:e27420. 10.1002\/pbc.27420","journal-title":"Pediatr Blood Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/QMH.0000000000000135","article-title":"Evidence-based practice standard care for acute pain management in adults with sickle cell disease in an urgent care center","volume":"26","author":"Kim S","year":"2017","unstructured":"Kim S, Brathwaite R, Kim O. Evidence-based practice standard care for acute pain management in adults with sickle cell disease in an urgent care center. Qual Manag Health Care. 2017, 26:108-15. 10.1097\/QMH.0000000000000135","journal-title":"Qual Manag Health Care"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2010.10.012","article-title":"Increased clearance of morphine in sickle cell disease: implications for pain management","volume":"12","author":"Darbari DS","year":"2011","unstructured":"Darbari DS, Neely M, van den Anker J, Rana S. Increased clearance of morphine in sickle cell disease: implications for pain management. J Pain. 2011, 12:531-8. 10.1016\/j.jpain.2010.10.012","journal-title":"J Pain"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2013.02.004","article-title":"Emergency provider analgesic practices and attitudes toward patients with sickle cell disease","volume":"62","author":"Glassberg JA","year":"2013","unstructured":"Glassberg JA, Tanabe P, Chow A, Harper K, Haywood C Jr, DeBaun MR, Richardson LD. Emergency provider analgesic practices and attitudes toward patients with sickle cell disease. Ann Emerg Med. 2013, 62:293-302. 10.1016\/j.annemergmed.2013.02.004","journal-title":"Ann Emerg Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10030438","article-title":"Opioids and sickle cell disease: from opium to the opioid epidemic","volume":"10","author":"Ballas SK","year":"2021","unstructured":"Ballas SK. Opioids and sickle cell disease: from opium to the opioid epidemic. J Clin Med. 2021, 10:438. 10.3390\/jcm10030438","journal-title":"J Clin Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.15537\/smj.2020.10.25386","article-title":"Outcomes of multidisciplinary team interventions in the management of sickle cell disease patients with opioid use disorders. A retrospective cohort study","volume":"41","author":"Al Zahrani O","year":"2020","unstructured":"Al Zahrani O, Hanafy E, Mukhtar O, Sanad A, Yassin W. Outcomes of multidisciplinary team interventions in the management of sickle cell disease patients with opioid use disorders. A retrospective cohort study. Saudi Med J. 2020, 41:1104-10. 10.15537\/smj.2020.10.25386","journal-title":"Saudi Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/76467-opioid-use-in-patients-with-sickle-cell-disease-during-a-vaso-occlusive-crisis-a-systematic-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:12Z","timestamp":1707507372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/76467-opioid-use-in-patients-with-sickle-cell-disease-during-a-vaso-occlusive-crisis-a-systematic-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,21]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.21473","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,21]]}}}